Ticking boxes. One day the mkt will notice.
"Second Ghent study demonstrates DOPlify™ suitability for liquid biopsy applications Highlights Second University of Ghent study published demonstrating DOPlify™ is internationally competitive for cell-based liquid biopsy applications New results reinforce the earlier Ghent study published in July 2017 that DOPlify™ is a world leading Whole Genome Amplification kit
Ticking boxes. One day the mkt will notice. "Second Ghent study...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)